Cited by 131Tryptophan and brain disordersSchizophrenia research and treatmentNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

Open access

Hope, Sigrun, Ueland, Thor, Steen, Nils Eiel, Dieset, Ingrid, Lorentzen, Steinar, Berg, Akiah O., Agartz, Ingrid, Aukrust, Pål, Andreassen, Ole A.·2013·Schizophrenia Research

DOI 10.1016/j.schres.2012.12.023

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Previous studies suggest elevated inflammation in schizophrenia and bipolar disorder, with increased activity of the Interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor (TNF)-alpha, von Willebrand factor (vWf) and osteoprotegerin (OPG). It is unclear how immune activation is involved in the psychopathology. We investigated if elevated inflammation was associated with disease severity (trait) or current symptom level (state), comparing psychotic with general characteristics. METHODS: Plasma levels of sTNF receptor 1 (sTNF-R1), IL-1 receptor antagonist (IL-1Ra), IL-6, vWf and OPG were measured with ELISA techniques in 322 patients with schizophrenia spectrum and bipolar disorder. Current symptom level (state) was measured with Global Assessment of Functioning (GAF) and Positive and Negative Syndrome Scale (PANSS). Disease severity (trait) was measured with premorbid adjustment scale (PAS), age at onset, number of psychotic episodes and number and length of hospitalizations. RESULTS: After controlling for confounders, IL-1Ra and TNF-R1 were independently associated with GAF, and significantly correlated with PANSS negative and positive, respectively. In addition, Il-1Ra was associated with PAS, and sTNF-R1 with number of hospitalizations and psychotic episodes. VWf was significantly correlated with psychotic episodes, OPG with hospitalizations and IL-6 with history of psychosis. Linear regression analysis showed that GAF remained associated with sTNF-R1 and IL-1Ra with PANSS, after controlling for the other clinical measures. CONCLUSIONS: This supports that inflammatory markers, particularly IL-1Ra and sTNF-R1 are associated with both general disease severity and psychotic features. This supports a role of immune activation in the core pathological mechanisms of severe mental disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2012.12.023

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Bipolar Disorder
Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515
MANIC DEPRESSIVE ILLNESS
Davenport, Y. B., Adland, M. L., Gold, P. W., & Goodwin, F. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Manic-depressive illness
Papageorgis, D. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90087-j · Cited by 1,537
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Evidence for a cytokine model of cognitive function
McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760
Psychiatric genetics: progress amid controversy
Burmeister, M., McInnis, M. G., & Zöllner, S. K. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2381 · Cited by 541

Show all 66 references

Sorted by citations

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Microbiota-gut-brain axis and the central nervous system
Zhu, X., Han, Y., Du, J., Liu, R., Jin, K., & Yi, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17754 · Cited by 308
Microbiota regulation of the mammalian gut-brain axis
Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
Köhler-Forsberg, O., Buttenschøn, H. N., Tansey, K. E., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., Rietschel, M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.020 · Cited by 283
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 293
Cytokine Alterations in Schizophrenia: An Updated Review
Momtazmanesh, S., Zare-Shahabadi, A., & Rezaei, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00892 · Cited by 277
The Gut-Brain Axis, BDNF, NMDA and CNS Disorders
Maqsood, R., & Stone, T. W. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2039-1 · Cited by 231
A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients
Sayana, P., Colpo, G. D., Simões, L. R., Giridharan, V. V., Teixeira, A. L., Quevedo, J., & Barichello, T. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.018 · Cited by 196
Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
Anand, N., Gorantla, V. R., & Chidambaram, S. B. (2022) · Cells · doi:10.3390/cells12010054 · Cited by 194
The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia
Roomruangwong, C., Noto, C. D. S., Kanchanatawan, B., Anderson, G., Kubera, M., Carvalho, A. F., & Maes, M. H. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01737-z · Cited by 162
Schizophrenia and the gut–brain axis
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.018 · Cited by 151
Bipolar Disorder: Role of Immune-Inflammatory Cytokines, Oxidative and Nitrosative Stress and Tryptophan Catabolites
Anderson, G., & Maes, M. H. J. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0541-1 · Cited by 148
Inflammatory signaling mechanisms in bipolar disorder
Jones, G. H., Vecera, C. M., Pinjari, O. F., & Machado‐Vieira, R. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00742-6 · Cited by 148
Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship
Rodrígues-Amorím, D., Baltanás, T. R., Spuch, C., Caruncho, H. J., González‐Fernández, Á., Olivares, J. M., & Agís‐Balboa, R. C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.023 · Cited by 120
Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms
Cattane, N., Richetto, J., & Cattaneo, A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.001 · Cited by 129
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
Noto, C. D. S., Maes, M. H. J., Ota, V., Teixeira, A. L., Bressan, R. A., Gadelha, A., & Brietzke, E. M. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1062552 · Cited by 116
Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers – pre-clinical and clinical investigations
Prata, J., Santos, S. G., Almeida, M. I., Coelho, R., & Barbosa, M. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0938-y · Cited by 115
Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
Hope, S., Hoseth, E. Z., Dieset, I., Mørch, R. H., Aas, M., Aukrust, P., Djurovic, S., Melle, I. S., Ueland, T., Agartz, I., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.004 · Cited by 114
Self-citation
Probiotics and prebiotics: focus on psychiatric disorders – a systematic review
Barbosa, R. S. D., & Vieira‐Coelho, M. A. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz080 · Cited by 103
A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms
Ng, Q. X., Soh, A. Y. S., Venkatanarayanan, N., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2019) · Neuropsychobiology · doi:10.1159/000498862 · Cited by 87
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 88
Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
Solberg, D. K., Bentsen, H., Refsum, H., & Andreassen, O. A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1006-3 · Cited by 82
Self-citation
Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: Relationship to psychopathology
Xiu, M. H., Yang, G. G., Tan, Y., Chen, D. C., Tan, S., Wang, Z. R., Yang, F. D., Okusaga, O. O., Soares, J. C., & Zhang, X. Y. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.024 · Cited by 79
A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder
Bai, Y., Chen, M., Hsu, J.-W., Huang, K., Tu, P., Chang, W.-C., Su, T., Li, C., Lin, W.-C., & Tsai, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1724-9 · Cited by 76
The gut microbiota in neuropsychiatric disorders
Grochowska, M., Wojnar, M., & Radkowski, M. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-008 · Cited by 77
Therapeutic effect of aripiprazole in chronic schizophrenia is accompanied by anti-inflammatory activity
Sobiś, J., Rykaczewska-Czerwińska, M., Świętochowska, E., & Gorczyca, P. W. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.007 · Cited by 72
The Neurobiology of Bipolar Disorder: An Integrated Approach
Muneer, A. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.1.18 · Cited by 68
Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder.
Siwek, M., Sowa-Kućma, M., Styczeń, K., Misztak, P., Nowak, R. J., Szewczyk, B., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0124-8 · Cited by 65
Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
Fourrier, C., Sampson, E., Mills, N. T., & Baune, B. T. (2018) · Trials · doi:10.1186/s13063-018-2829-7 · Cited by 66
Markers of inflammation in schizophrenia: association vs. causation
Manu, P., Correll, C. U., Wampers, M., Mitchell, A. J., Probst, M., Vancampfort, D., & De Hert, M. (2014) · World Psychiatry · doi:10.1002/wps.20117 · Cited by 59
A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia
Solberg, D. K., Refsum, H., Andreassen, O. A., & Bentsen, H. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.14 · Cited by 59
Self-citation
Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors
Mørch, R. H., Dieset, I., Færden, A., Reponen, E. J., Hope, S., Hoseth, E. Z., Gardsjord, E. S., Aas, M., Iversen, T., Joa, I., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718004142 · Cited by 58
Self-citation
Acute phase response after fatal traumatic brain injury
Ondruschka, B., Schuch, S., Pohlers, D., Franke, H., & Dressler, J. (2018) · Zeitschrift für Rechtsmedizin · doi:10.1007/s00414-017-1768-2 · Cited by 48
Neuromarkers for Mental Disorders: Harnessing Population Neuroscience
Jollans, L., & Whelan, R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00242 · Cited by 56
Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells
Akkouh, I. A., Ueland, T., Hansson, L. J., Inderhaug, E., Hughes, T., Steen, N. E., Aukrust, P., Andreassen, O. A., Szabó, A., & Djurovic, S. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.02.008 · Cited by 56
Self-citation
The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management
Saleki, K., Alijanizadeh, P., Javanmehr, N., & Rezaei, N. (2024) · Medicinal Research Reviews · doi:10.1002/med.22012 · Cited by 56
Characterization of salivary proteins of schizophrenic and bipolar disorder patients by top-down proteomics
Iavarone, F., Melis, M., Platania, G., Cabras, T., Manconi, B., Petruzzelli, R., Cordaro, M., Siracusano, A., Faa, G., Messana, I., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.03.020 · Cited by 53
Association between cytokine levels, verbal memory and hippocampus volume in psychotic disorders and healthy controls
Hoseth, E. Z., Westlye, L. T., Hope, S., Dieset, I., Aukrust, P., Melle, I. S., Haukvik, U. K., Agartz, I., Ueland, T., Ueland, T., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12467 · Cited by 51
Self-citation
Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia
Kissi, Y. E., Samoud, S., Mtiraoui, A., Letaief, L., Hannachi, N., Ayachi, M., Ali, B. B. H., & Boukadida, J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.007 · Cited by 51
Increased circulating regulatory T cells in medicated people with schizophrenia
Kelly, D. L., Li, X., Kilday, C., Feldman, S. M., Clark, S. M., Liu, F., Buchanan, R. W., & Tonelli, L. H. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.006 · Cited by 53
Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review
Buoli, M., Caldiroli, A., Melter, C. C., Serati, M., de Nijs, J., & Altamura, A. C. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12386 · Cited by 49
Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients
Pandey, G. N., Ren, X., Rizavi, H. S., & Zhang, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.004 · Cited by 46
The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study
Al‐Hakeim, H. K., Almulla, A. F., & Maes, M. H. J. (2020) · Neurotoxicity Research · doi:10.1007/s12640-019-00112-z · Cited by 49
Inflammatory evidence for the psychosis continuum model
Mørch, R. H., Dieset, I., Færden, A., Hope, S., Aas, M., Nerhus, M., Gardsjord, E. S., Joa, I., Morken, G., Agartz, I., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.02.011 · Cited by 42
Self-citation
Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder
Pandey, G. N., Ren, X., Rizavi, H. S., & Zhang, H. (2015) · Bipolar Disorders · doi:10.1111/bdi.12320 · Cited by 40
Low vitamin D is associated with negative and depressive symptoms in psychotic disorders
Nerhus, M., Berg, A. O., Kvitland, L. R., Dieset, I., Hope, S., Dahl, S. R., Weibell, M. A., Romm, K. L., Færden, A., Andreassen, O. A., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.08.024 · Cited by 42
Self-citation
Research and Diagnostic Algorithmic Rules (RADAR) for mood disorders, recurrence of illness, suicidal behaviours, and the patient’s lifetime trajectory
Maes, M. H. J., Moraes, J. B., Congio, A. C., Vargas, H. O., & Nunes, S. O. V. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.31 · Cited by 33
C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis
Melbourne, J. K., Rosen, C., Feiner, B., & Sharma, R. P. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.01.018 · Cited by 35
The brain-gut axis dysfunctions and hypersensitivity to food antigens in the etiopathogenesis of schizophrenia
Karakuła‐Juchnowicz, H., Dzikowski, M., Pelczarska-Jamroga, A., Dzikowska, I., & Juchnowicz, D. (2015) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/45053 · Cited by 35
White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder
Köhler, O., Sylvia, L. G., Bowden, C. L., Calabrese, J. R., Thase, M., Shelton, R. C., McInnis, M., Tohen, M., Kocsis, J. H., Ketter, T. A., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416644508 · Cited by 33
Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology
González-Blanco, L., García‐Portilla, M. P., Santo, F. D., García-Álvarez, L., de la Fuente-Tomás, L., Menéndez-Miranda, I., Bobes-Bascarán, T., Sáiz, P. A., & Bobes, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112509 · Cited by 33
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
Bashir, Y., & Khan, A. U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1030694 · Cited by 35
TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder
Millett, C. E., Harder, J., Locascio, J. J., Shanahan, M., Santone, G., Fichorova, R. N., Corrigan, A., Baecher‐Allan, C., & Burdick, K. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.003 · Cited by 32
Further evidence for plasma progranulin as a biomarker in bipolar disorder
Kittel-Schneider, S., Weigl, J., Volkert, J., Geßner, A., Schmidt, B., Hempel, S., Kiel, T., Olmes, D. G., Bartl, J., Weber, H., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.01.006 · Cited by 32
Biological aspects and candidate biomarkers for rapid-cycling in bipolar disorder: A systematic review
Buoli, M., Serati, M., & Altamura, A. C. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.08.059 · Cited by 30
Pro-inflammatory cytokines and suicidal behavior among patients with bipolar I disorder
Huang, M., Chen, M., Chan, Y. E., Li, C., Tsai, S., Bai, Y., & Su, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.030 · Cited by 30
The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia
Turhan, L., Batmaz, S., Koçbıyık, S., & Soygur, A. H. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1122079 · Cited by 29
VRK2 gene expression in schizophrenia, bipolar disorder and healthy controls
Tesli, M., Wirgenes, K. V., Hughes, T., Bettella, F., Athanasiu, L., Hoseth, E. Z., Nerhus, M., Lagerberg, T. V., Steen, N. E., Agartz, I., et al. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.161950 · Cited by 26
Self-citation
Persistent increase in TNF and IL‐1 markers in severe mental disorders suggests trait‐related inflammation: a one year follow‐up study
Mørch, R. H., Dieset, I., Færden, A., Hope, S., Aas, M., Nerhus, M., Gardsjord, E. S., Haram, M., Falk, R. S., Joa, I., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12783 · Cited by 28
Self-citation
Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
Ioannou, M., Foiselle, M., Mallet, J., Stam, E. L., Godin, O., Dubertret, C., Terro, E., Sommer, I. E., Haarman, B. C. M., Leboyer, M., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.001 · Cited by 28
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
Filho, A. J. M. C., Cunha, N. L., Rodrigues, P. D. A., de Souza, A. G., Soares, M. V.-R., Jucá, P. M., de Queiroz, T., Clemente, D. C. D. S., Mottin, M., Andrade, C. H., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.007 · Cited by 28
Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder
Zazula, R., Dodd, S., Dean, O. M., Berk, M., Bortolasci, C. C., Verri, W. A., Jr., Vargas, H. O., & Nunes, S. O. V. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1925152 · Cited by 31
Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal
Re, G.-F., Jia, J., Xu, Y., Zhang, Z., Xie, Z., Kong, D., Lu, D., Li, Y., Peng, Q., Yu, J., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108696 · Cited by 25
Increased prefrontal cortical cells positive for macrophage/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia
Zhu, Y., Webster, M. J., Walker, A. K., Massa, P. T., Middleton, F. A., & Weickert, C. S. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.018 · Cited by 25
Association between serum lipid levels, osteoprotegerin and depressive symptomatology in psychotic disorders
Gohar, S. M., Dieset, I., Steen, N. E., Mørch, R. H., Iversen, T., Steen, V. M., Andreassen, O. A., & Melle, I. S. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0897-z · Cited by 28
Self-citation
Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation
Konefal, S., & Stellwagen, D. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0160 · Cited by 26
Over-expression of TGF-β1 gene in medication free Schizophrenia
Amoli, M. M., Khatami, F., Arzaghi, S. M., Enayati, S., & Nejatisafa, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.009 · Cited by 25
Targeting Neuroinflammation in Schizophrenia: A comprehensive review of mechanisms and pharmacological interventions
Huang, H., Luo, Z., Min, J., Luo, W., Zhou, X., & Wang, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114910 · Cited by 25
Biomarcadores de estrés oxidativo y dimensiones clínicas en los 10 primeros años de esquizofrenia
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.03.003 · Cited by 23
Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia
García-Álvarez, L., García‐Portilla, M. P., González-Blanco, L., Sáiz, P. A., de la Fuente-Tomás, L., Menéndez-Miranda, I., García, C. I., & Bobes, J. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2016.04.003 · Cited by 20
Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature
Ramirez, O. M., Arias, J. C., Duica, K., Zuluaga, A. M. D., Vargas, C., & López‐Jaramillo, C. (2017) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2017.01.004 · Cited by 22
Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.03.001 · Cited by 18
Bipolar Disorder
Grunze, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00040-9 · Cited by 16
Neuroinflammation and excitatory symptoms in bipolar disorder
Sani, G., Panaccione, I., & Spalletta, G. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.167304 · Cited by 17
The Role of Aberrations in the Immune-inflammatory Reflex System (IRS) and the Compensatory Immune-regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: The IRS-CIRS Theory of SchizophreniaPreprint
Roomruangwong, C., Noto, C. D. S., Kanchanatawan, B., Anderson, G., Kubera, M., Carvalho, A. F., & Maes, M. H. J. (2018) · Preprints.org · doi:10.20944/preprints201809.0289.v1 · Cited by 15
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder.
Köhler-Forsberg, O., Sylvia, L., Deckersbach, T., Ostacher, M. J., McInnis, M., Iosifescu, D., Bowden, C., McElroy, S., Calabrese, J., Thase, M., et al. (2018) · Acta Neuropsychiatrica · doi:10.1017/neu.2017.34 · Cited by 15
Differential blood-based biomarkers of psychopathological dimensions of schizophrenia
García-Álvarez, L., García‐Portilla, M. P., González-Blanco, L., Martinez, P. A. S., de la Fuente-Tomás, L., Menéndez-Miranda, I., García, C. I., & Bobes, J. (2016) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2016.04.008 · Cited by 15
Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII
Department of Psychiatry, G. U., Kucukkarapinar, M., Erbil, D., Department of Psychiatry, G. U., Keles, İ., Department of Psychiatry, G. U., Karadag, F., & Department of Psychiatry, G. U. (2024) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2024.23760 · Cited by 14
Psychotic features, particularly mood incongruence, as a hallmark of severity of bipolar I disorder
Elowe, J., Vallat, J., Castelao, E., Strippoli, M. F., Gholam‐Rezaee, M., Ranjbar, S., Glaus, J., Merikangas, K. R., Lavigne, B., Marquet, P. P., et al. (2022) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00280-6 · Cited by 14
Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders
Archer, T., Ricci, S., Garcia, D., & Ricciardi, M. R. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9473-0 · Cited by 14
Higher Serum C-Reactive Protein Levels in Catatonic Patients: A Comparison to Non-catatonic Patients and Healthy Controls
Zhou, F., Lee, J. W. Y., Zhang, Q.-H., Sun, Z.-L., Bo, Q., He, X., Han, T., Xiong, M., Li, C., & Wang, C. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa041 · Cited by 12
Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder
Wartchow, K. M., Scaini, G., & Quevedo, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_9 · Cited by 12
¿Pueden ser la interleucina-2 y la interleucina-1β biomarcadores específicos de la sintomatología negativa en la esquizofrenia?
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2018) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2018.03.004 · Cited by 10
Levels of TNF alpha , soluble TNF receptors (sTNF-R1, sTNF-R2) in bipolar disorder
Baysal, Ö. D., Erdogan, A. R., Ci̇nemre, B., Akbas, H. S., Kaya, S. S., & Kus, S. (2019) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.24844 · Cited by 10
Probiotics: A potential immunotherapeutic approach for the treatment of schizophrenia
Patil, A., Grover, S., Kaur, A., & Garg, G. (2019) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_47_19 · Cited by 10
Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia
Buchanan, R. W., Weiner, E., Kelly, D. L., Gold, J. M., Chen, S., Zaranski, J., Blatt, F., Wehring, H. J., & Carpenter, W. T. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001253 · Cited by 9
Quantitative detection of methylated SOCS-1 in schizophrenia and bipolar disorder considering SOCS-1 -1478CA/del polymorphism and clinical parameters
Aytaç, H. M., Pehlıvan, S., Pehlıvan, M., & Oyacı, Y. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03030-w · Cited by 9
Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders
Werner, M. C. F., Wirgenes, K. V., Shadrin, A. A., Lunding, S. H., Rødevand, L. N., Hjell, G., Ormerod, M. B. E. G., Haram, M., Agartz, I., Djurovic, S., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110511 · Cited by 10
Self-citation
Importance of ‘inflammatory molecules’, but not necessarily of inflammation, in the pathophysiology of bipolar disorder and in the mechanisms of action of anti-bipolar drugs
Hertz, L., Song, D., Li, B., Yan, E., & Peng, L. (2013) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2013.09.004 · Cited by 7
Biomarker Identification and Effect Estimation on Schizophrenia – A High Dimensional Data Analysis
Li, Y., Yolken, R. H., Cowan, D. N., Boivin, M. R., Liu, T., & Niebuhr, D. W. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00075 · Cited by 7
Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?
González-Blanco, L., García‐Portilla, M. P., García-Álvarez, L., de la Fuente-Tomás, L., García, C. I., Sáiz, P. A., Rodríguez‐González, S., Coto‐Montes, A. M., & Bobes, J. (2019) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2018.03.003 · Cited by 7
Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure
Lai, J., Liu, Y., Pan, C., Lin, C., Sun, F., Huang, Z., Lin, Y., Zhou, R., Lin, Y., & Zhou, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4361 · Cited by 6
Risk factors of major infections in schizophrenia. A nationwide Danish register study
Pankiewicz-Dulacz, M., Stenager, E., Chen, M., & Stenager, E. N. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.04.003 · Cited by 6
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials
Köhler‐Forsberg, O., Sylvia, L. G., Bowden, C. L., Calabrese, J. R., Thase, M. E., Shelton, R. C., McInnis, M. G., Tohen, M. F., Kocsis, J. H., Ketter, T. A., et al. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.19 · Cited by 6
Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results
Anmella, G., Amoretti, S., Safont, G., Meseguer, A., Vieta, E., Pons-Cabrera, M. T., Alfonso, M., Hernández, C., Sánchez-Autet, M., Pérez-Baldellou, F., et al. (2023) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2023.09.005 · Cited by 7
Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review
Kiecka, A., & Szczepanik, M. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00584-7 · Cited by 6
Distinct Gut Microbial Signatures and Diminished Anti-Inflammatory Effect of Short-Chain Fatty Acids in Schizophrenia With Immune Activation
He, X., Gao, Y., Zhang, Y., Yang, Z., Wang, C., Ma, Q., Lei, P., Lu, Y., Fan, Y., Liu, R., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf110 · Cited by 5
Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population
Pehlıvan, S., Oyacı, Y., Tunçel, F. C., & Aytaç, H. M. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00341-6 · Cited by 5

Authors: Hope, S., Ueland, T., Steen, N. E., Dieset, I., Lorentzen, S., Berg, A. O., Agartz, I., Aukrust, P., & Andreassen, O. A.
Affiliations: Oslo University Hospital (NO)
University of Oslo (NO)
Corresponding author: Hope, Sigrun
ORCID: Hope, Sigrun
Ueland, Thor
Steen, Nils Eiel
Dieset, Ingrid
Lorentzen, Steinar
Berg, Akiah O.
Agartz, Ingrid
Aukrust, Pål
Andreassen, Ole A.
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2013-04
Volume: 145
Issue: 1-3
Pages: 36-42
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2012.12.023
OpenAlex: W2079187454
Cited by: 131
References: 66
Citations by year: 2026: 2 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 7 · 2020: 12 · 2019: 15 · 2018: 16 · 2017: 13 · 2016: 16 · 2015: 11 · 2014: 11 · 2013: 3
FWCI: 4.61
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 106 d)
Locations: Schizophrenia Research (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor 1
MeSH terms: Adolescent, Adult, Aged, Bipolar Disorder, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Psychotic Disorders, Regression Analysis, Schizophrenia, Severity of Illness Index, von Willebrand Factor, Interleukin-6, Receptors, Tumor Necrosis Factor, Osteoprotegerin, Interleukin 1 Receptor Antagonist Protein, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks